AION Diagnostics
AION Diagnostics: AION commences trading on Xetra Trading System
AION Diagnostics / Miscellaneous Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Perth, Australia – AION Diagnostics Inc, a nano-diagnostics company developing medical imaging agents, announced that its common stock has been accepted for inclusion on the Xetra trading system of the Deutsche Börse. Xetra is an electronic trading platform and operates independently of the trader's location, providing insight into order book documentation. Xetra will offer fully electronic securities trading to increase AION’s share liquidity on the Frankfurt Stock Exchange. - ENDS - Released by: AION Diagnostics Alexandra Brown Ph: +61 (8) 6461 9400 alexandra_brown@aiondiagnostics.com European Public Relations Dr. Eva Reuter Ph: +49 (254) 393 0740 e.reuter@e-reuter-ir.com This press release and the information contained therein do not constitute an offer for sale or a solicitation for submission of an offer for purchase or subscription of shares in AION Diagnostics Inc in Germany nor outside Germany, especially in the United States, Canada, Japan or the United Kingdom and Northern Ireland. This press release is provided solely for information purposes. DGAP 21.05.2007 ----------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden